Clinical trial

Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate

NCT00598858

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE2

Study timeline

Study start (unknown)2009-01-01Date precision: month

Registry last updated2016-12-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Adenocarcinoma of the Prostateunresolved

Stage I Prostate Cancerunresolved

Stage II Prostate Cancerunresolved

Interventions

DocetaxelDRUG · verified · RxNorm: docetaxel

PrednisoneDRUG · verified · RxNorm: prednisone

Sponsors & collaborators

John P. Fruehauflead sponsor

Sanoficollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00598858 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.